Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $80.50 $93.35 Friday, 10th May 2024 BMRN stock ended at $81.03. This is 0.84% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.50% from a day low at $80.74 to a day high of $81.95.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Aug 11, 2016 $91.93 $92.81 $90.66 $92.01 1 304 900
Aug 10, 2016 $94.89 $95.10 $90.92 $91.45 2 209 700
Aug 09, 2016 $94.62 $95.94 $93.74 $95.15 5 179 500
Aug 08, 2016 $99.29 $99.62 $97.70 $99.02 1 442 200
Aug 05, 2016 $100.88 $101.67 $98.50 $98.94 2 088 600
Aug 04, 2016 $102.41 $102.49 $99.14 $99.62 1 458 000
Aug 03, 2016 $99.03 $101.70 $98.76 $101.46 1 684 800
Aug 02, 2016 $99.96 $100.90 $97.40 $99.07 1 926 600
Aug 01, 2016 $99.33 $101.30 $98.51 $100.25 2 102 100
Jul 29, 2016 $98.18 $99.62 $96.17 $99.42 1 448 300
Jul 28, 2016 $98.80 $99.50 $96.64 $98.20 2 503 200
Jul 27, 2016 $91.58 $98.71 $90.52 $98.09 5 832 300
Jul 26, 2016 $93.27 $93.43 $91.21 $92.02 2 160 800
Jul 25, 2016 $94.02 $94.43 $92.55 $92.79 1 162 500
Jul 22, 2016 $93.78 $95.49 $93.36 $93.58 1 235 200
Jul 21, 2016 $92.00 $94.87 $91.91 $93.36 1 859 500
Jul 20, 2016 $91.57 $94.02 $90.66 $93.76 1 506 400
Jul 19, 2016 $93.49 $94.00 $90.20 $90.42 1 150 700
Jul 18, 2016 $92.23 $94.38 $89.57 $92.86 2 381 600
Jul 15, 2016 $89.79 $94.75 $89.19 $92.08 2 915 900
Jul 14, 2016 $88.19 $89.64 $86.16 $89.03 1 448 500
Jul 13, 2016 $88.44 $88.48 $85.86 $87.12 1 943 900
Jul 12, 2016 $88.83 $89.98 $87.43 $87.48 1 724 200
Jul 11, 2016 $91.82 $91.82 $88.59 $88.59 1 884 100
Jul 08, 2016 $87.81 $93.04 $87.50 $91.49 3 766 700
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT